Massachusetts · Compounded Semaglutide
Compounded Semaglutide for Massachusetts Residents — Physician-Led Telehealth from $86/mo
Ozari connects Massachusetts residents with licensed telehealth clinicians who review medical eligibility online and, when appropriate, prescribe compounded semaglutide. Plans start at $86/month on the 3-Month Starter Plan for eligible first-time GLP-1 patients, with published tiers and no insurance requirement.
Prescriptions are filled by Ozari's named 503A partners — Hallandale Pharmacy (PCAB-accredited) and VialsRx (USP 797 sterile compounding) — and shipped directly to your Massachusetts address.
Compounded semaglutide and tirzepatide are prescribed for documented individual patient need by licensed physicians and prepared by licensed U.S. compounding pharmacies. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality.
Start Online Visit
Quick Answer
Compounded semaglutide is a patient-specific prescription prepared by a licensed U.S. compounding pharmacy; it is not an FDA-approved finished product like branded Wegovy. For Massachusetts residents, Ozari's model is fully online: complete a health intake, receive physician review, get a prescription sent to a named 503A pharmacy if clinically appropriate, and receive medication at home with plans from $86/month on the Starter tier.
Published pricing for Massachusetts patients
All plans below are sourced from Ozari's current treatment pricing. No insurance required.
Tap to switch plan type
$257 billed every 3 months
Save $268
Pricing last verified: July 28, 2026
Branded comparison: Retail pharmacy cash pricing for branded Wegovy often exceeds $1,000 per month without manufacturer programs. Through NovoCare self-pay, Wegovy is listed at $199 per month for the first two qualifying fills, then $349 per month for standard doses under current manufacturer terms — verify NovoCare before comparing.
Telehealth access for Massachusetts patients
Massachusetts has a robust telehealth regulatory framework, and the Massachusetts Board of Registration in Medicine permits physicians to prescribe through synchronous video consultations without requiring a prior in-person visit. The state requires insurers to cover telehealth equivalently to in-person care under MGL Chapter 175. Massachusetts is also home to major GLP-1 clinical research institutions, and patient awareness of and demand for GLP-1 therapies is among the highest in the country.
How Ozari's process works
A physician-led workflow designed for Massachusetts patients who want transparent pricing and named pharmacy partners.
Step 1
Complete your online intake
Answer structured health questions from anywhere in Massachusetts. Most patients finish in under 10 minutes.
Step 2
Physician review and eligibility decision
A licensed clinician reviews your history, contraindications, and goals before any prescription is written.
Step 3
Pharmacy fulfillment and home delivery
If prescribed, your order is prepared by a licensed 503A partner pharmacy and shipped to your Massachusetts address with cold-chain packaging when required.
Step 4
Ongoing clinical support
Message your care team for titration questions, side effects, and refills instead of navigating clinic phone trees.
Named pharmacy partners
Ozari does not sell semaglutide from inventory. Every order is patient-specific, written by a licensed prescriber, and prepared by either Hallandale Pharmacy — a PCAB-accredited 503A facility in Fort Lauderdale, Florida — or VialsRx, a U.S.-licensed 503A pharmacy compounding under USP 797 standards. Your shipment label identifies the dispensing pharmacy. Ozari Health holds LegitScript certification for its telehealth platform, which third parties can verify independently.
Hallandale Pharmacy
PCAB-accredited 503A compounding pharmacy in Fort Lauderdale, Florida
VialsRx
U.S.-licensed 503A compounding pharmacy operating under USP 797 sterile compounding standards
City pages in Massachusetts
Local delivery context and pricing for major Massachusetts metros.
Frequently asked questions
Common questions from Massachusetts patients considering compounded semaglutide.
Compounded semaglutide is prepared by a licensed 503A pharmacy for an individual prescription. Branded Wegovy is an FDA-approved finished product with a full FDA review of safety, efficacy, and manufacturing. Compounded versions are not FDA-approved, not generic equivalents, and are prescribed only when a licensed clinician determines they are appropriate for your history.
Ozari publishes flat-rate plans for Massachusetts: $86/month equivalent on the 3-Month Starter Plan ($257 every 3 months, first-time GLP-1 users), $145/month on Quarterly ($435 every 3 months), or $175/month month-to-month. Free shipping is included; no insurance is required.
Safety depends on appropriate prescribing, pharmacy standards, and follow-up care — not price alone. Ozari uses named 503A partners (Hallandale Pharmacy, PCAB-accredited; VialsRx, USP 797) and a LegitScript-certified telehealth platform. Compounded products are still not FDA-approved finished drugs, so your clinician must review contraindications before treatment.
You complete a secure online intake, a licensed clinician reviews your record, and a prescription is sent to a 503A partner pharmacy only if treatment is medically appropriate. Medication ships to your Massachusetts address. There is no checkout without clinician review.
In STEP 1 (NEJM 2021), FDA-approved semaglutide 2.4 mg with lifestyle support produced a mean 14.9% body weight reduction at 68 weeks versus 2.4% with placebo. Published trial averages are not guarantees for compounded products or for any individual patient.
Massachusetts has a robust telehealth regulatory framework, and the Massachusetts Board of Registration in Medicine permits physicians to prescribe through synchronous video consultations without requiring a prior in-person visit. The state requires insurers to cover telehealth equivalently to in-person care under MGL Chapter 175.
Ozari routes prescriptions to Hallandale Pharmacy (PCAB-accredited 503A, Fort Lauderdale, FL) or VialsRx (U.S.-licensed 503A, USP 797). Your vial label and patient materials identify the dispensing pharmacy for that shipment.
Yes. Eligible Massachusetts patients receive free expedited shipping to residential or business addresses statewide once a prescription is approved and filled. Cold-chain packaging is used when required for medication stability in transit.
Ready to start in Massachusetts?
Complete your intake online. A licensed clinician reviews your information before any prescription is written.
Start Online Visit